News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,152 Results
Type
Article (4989)
Company Profile (22)
Press Release (217141)
Section
Business (82225)
Career Advice (462)
Deals (15046)
Drug Delivery (8)
Drug Development (19094)
Employer Resources (30)
FDA (3677)
Job Trends (3906)
News (120159)
Policy (7502)
Tag
Academia (291)
Alliances (14730)
Alzheimer's disease (219)
Approvals (3676)
Bankruptcy (94)
Best Places to Work (2859)
Biotechnology (24)
Breast cancer (37)
Cancer (289)
Career advice (392)
Cell therapy (64)
Clinical research (15789)
Collaboration (93)
Compensation (86)
COVID-19 (300)
C-suite (55)
Data (344)
Diabetes (25)
Diagnostics (2003)
Earnings (40032)
Employer resources (31)
Events (37153)
Executive appointments (149)
FDA (3810)
Funding (107)
Gene therapy (28)
GLP-1 (98)
Government (407)
Healthcare (5006)
Infectious disease (312)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7754)
Job creations (1120)
Job search strategy (361)
Layoffs (96)
Legal (2322)
Lung cancer (30)
Manufacturing (32)
Medical device (3827)
Medtech (3828)
Mergers & acquisitions (7357)
Metabolic disorders (78)
Neuroscience (272)
NextGen Class of 2024 (1671)
Non-profit (725)
Northern California (576)
Obesity (39)
Opinion (28)
People (24220)
Phase I (4710)
Phase II (6859)
Phase III (5459)
Pipeline (269)
Postmarket research (625)
Preclinical (1843)
Press Release (66)
Radiopharmaceuticals (104)
Rare diseases (41)
Real estate (1869)
Regulatory (4999)
Research institute (299)
Resumes & cover letters (68)
Southern California (435)
Startups (1006)
United States (4574)
Vaccines (25)
Date
Today (10)
Last 7 days (173)
Last 30 days (637)
Last 365 days (11043)
2024 (10817)
2023 (13214)
2022 (18689)
2021 (19727)
2020 (18283)
2019 (13227)
2018 (10210)
2017 (10002)
2016 (9157)
2015 (12120)
2014 (9589)
2013 (7707)
2012 (8331)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11318)
Australia (1565)
California (1181)
Canada (496)
China (34)
Colorado (47)
Connecticut (65)
Europe (24054)
Florida (157)
Georgia (25)
Idaho (23)
Illinois (80)
Indiana (40)
Japan (35)
Kansas (23)
Maine (34)
Maryland (149)
Massachusetts (983)
Michigan (64)
Minnesota (104)
New Jersey (366)
New York (316)
North Carolina (249)
Northern California (576)
Ohio (38)
Pennsylvania (239)
South America (273)
Southern California (435)
Texas (145)
Utah (34)
Washington State (107)
222,152 Results for "emmes corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Press Releases
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
September 4, 2024
·
2 min read
Business
Emmes Appoints Peter Ronco as Chief Executive Officer
Emmes today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.
September 20, 2023
·
3 min read
BioCapital
Matt Bond Has Joined Emmes as Chief Financial Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Matt Bond has become its chief financial officer.
October 3, 2023
·
2 min read
Business
Emmes Acquires Essex Management
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the acquisition of Essex Management.
March 21, 2023
·
3 min read
Business
Kristin Judge Joins Emmes as Chief Growth Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Kristin Judge has joined as its chief growth officer, a newly created executive leadership position.
May 25, 2023
·
3 min read
Business
Emmes Hires Becky Marson as Chief People and Performance Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Becky Marson has joined the company as its chief people and performance officer.
April 3, 2023
·
2 min read
BioCapital
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
December 8, 2022
·
3 min read
BioCapital
Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute
Emmes announced that a team of its researchers contributed to a successful AIDS Malignancy Consortium study.
June 16, 2022
·
4 min read
1 of 22,216
Next
